United States
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
For Period Ended: December 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Attached Instruction Sheet Before Preparing Form. Please
Print or Type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
Not applicable.
Part I. Registrant Information
Full Name of Registrant:
INAMED Corporation
Address of Principal Executive Office:
3800 Howard Hughes Parkway
Suite 900
Las Vegas, Nevada 89109
Part II. Rules 12b-25(b) and (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)
[X] (a) The reasons described in reasonable detail in Part
III of this form could not be eliminated without
unreasonable effort or expense;
[ ] (b) The subject annual report, semi-annual report,
transition report on Form 10-K, Form 20-F, 11-K or Form
N-SAR, or portion thereof, will be filed on or before
the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition
report on Form 10-Q, or portion thereof, will be filed
on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if
applicable.
Part III - Narrative
State below in reasonable detail the reason why Form 10-K, 20-F,
11-K, 10-Q, N-SAR or the transition report or portion thereof
could not be filed within the prescribed time period.
As previously disclosed in its press release dated March 11, 1998
and on Form 8-K (the "March Form 8-K") filed with the S.E.C. on
March 16, 1998 (and amended on March 27, 1998), the Company's
independent accountant has resigned. The Company is in the
process of retaining a new independent accountant. The filing of
the audited annual report on Form 10-K for 1997 will be delayed
until such time as the new independent accountant is retained and
has had an opportunity to review and opine on the financial
statements for fiscal years 1996 and 1997.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to
this notification:
Ilan K. Reich, Executive Vice President, INAMED Corporation, 702/791-3388
(2) Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30
of the Investment Company Act of 1940 during the preceding
12 months or for such shorter periods that the registrant
was required to file such report(s) been filed? If the
answer is no, identify report(s).
[ ] Yes [X] No
Form 10-K for the period ended 12/31/96 with an
independent auditor's report
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal
year will be reflected by the earning statements to be
included in the subject report or portion thereof?
[X] Yes [ ] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
Given the fact that the 1996 audit remains open, the Company
is in the midst of negotiating a settlement of the breast implant
litigation, and the March Form 8-K included a number of areas of
concern raised by the former independent accountant, the Company
believes there will be changes in the results of operations.
However, it is unable to quantify those amounts at this time.
INAMED CORPORATION
Has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: March 31, 1998 By: /s/ Richard G. Babbitt
Chairman of the Board and Chief
Executive Officer
